- Home
- STRO vs CLDT Comparison
STRO vs CLDT Comparison
Compare STRO & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- CLDT
- Stock Information
- Founded
- STRO 2003
- CLDT 2009
- Country
- STRO United States
- CLDT United States
- Employees
- STRO N/A
- CLDT N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- CLDT Real Estate Investment Trusts
- Sector
- STRO Health Care
- CLDT Real Estate
- Exchange
- STRO Nasdaq
- CLDT Nasdaq
- Market Cap
- STRO 172.8M
- CLDT 450.5M
- IPO Year
- STRO 2018
- CLDT 2010
- Fundamental
- Price
- STRO $1.72
- CLDT $8.69
- Analyst Decision
- STRO Strong Buy
- CLDT Strong Buy
- Analyst Count
- STRO 7
- CLDT 2
- Target Price
- STRO $12.14
- CLDT $12.00
- AVG Volume (30 Days)
- STRO 1.1M
- CLDT 231.9K
- Earning Date
- STRO 11-13-2024
- CLDT 02-25-2025
- Dividend Yield
- STRO N/A
- CLDT 3.23%
- EPS Growth
- STRO N/A
- CLDT N/A
- EPS
- STRO N/A
- CLDT N/A
- Revenue
- STRO $160,955,000.00
- CLDT $313,268,000.00
- Revenue This Year
- STRO N/A
- CLDT N/A
- Revenue Next Year
- STRO N/A
- CLDT $3.83
- P/E Ratio
- STRO N/A
- CLDT N/A
- Revenue Growth
- STRO 230.90
- CLDT 1.77
- 52 Week Low
- STRO $1.67
- CLDT $7.60
- 52 Week High
- STRO $6.13
- CLDT $11.10
- Technical
- Relative Strength Index (RSI)
- STRO 29.77
- CLDT 38.79
- Support Level
- STRO $1.80
- CLDT $8.32
- Resistance Level
- STRO $2.15
- CLDT $8.82
- Average True Range (ATR)
- STRO 0.13
- CLDT 0.22
- MACD
- STRO 0.03
- CLDT -0.05
- Stochastic Oscillator
- STRO 10.42
- CLDT 37.76
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.